Bank of America’s Purple Biotech PPBT Stock Holding History

Bank of America’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3	Closed	-$2K	–	8000
2021 Q1	$2K	Buy	+3	New	+$2.8K	﹤0.01%	7251

Other funds holding PPBT

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CCM

Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

WTB

Washington Trust Bank Spokane, Washington $1.36B AUM 21.14% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Bank of America's PPBT Position: Q2 2021 in Review

Bank of America sold out of Purple Biotech (PPBT) in Q2 2021, closing a stake of 3 shares — an estimated $2K sold.

Bank of America first reported a position in PPBT in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 12 funds tracked by Wall St. Rank hold PPBT as of Q2 2021.

Bank of America reported no remaining Purple Biotech position as of Q2 2021 after selling out during the quarter.
Bank of America sold 3 Purple Biotech shares in Q2 2021, an estimated $2K.
Bank of America first reported a position in Purple Biotech in Q1 2021 and held it in 1 quarter.
Bank of America's Purple Biotech position peaked at $2K in Q1 2021.
12 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2021.

Based on Bank of America's 13F filing for Q2 2021, filed 16 Aug 2021.